New Technology for Assessing Ovarian Cancer Risk in Pelvic Masses
April 10, 2023
Transforming women’s gynecologic health
Ovarian cancer is rare, but it’s one of the top gynecologic cancer killers. Every year, thousands of women are diagnosed with pelvic masses which raises concern about the presence of ovarian cancer. Previously, physicians and patients might have felt that the only way to “be safe” when a woman presented with an mass was to remove the ovaries. Now, there is a company dedicated to changing this.
Aspira Women’s Health has developed a non invasive test, OvaWatchSM, intended for use in assessing the risk of ovarian cancer for women with adnexal masses, which gives confidence in a low probability of malignancy to allow more women to keep their ovaries while allowing healthcare providers to focus their attention on women with more troubling masses.
Aspira Women’s Health CEO, Nicole Sandford, talks more about this test as well as her own personal journey with an adnexal mass; and, expert in the field of gynecology, Dr. Gerard Reilly, explains the importance of early detection and how he uses this test in his practice.
Do you constantly apologize, even when there’s no reason to? Many women have been conditioned to be overly polite and accommodating, often undermining their own confidence and authority in the process. But that behavior is best left in the past. Now, it’s time to break free from the apology trap and reclaim your power. […]
Stay tuned as “Grillin with Dad” Maciek Zurawski and Chef Ralph Pagano grill up various cuts of beef — from NY Strip to Ribeye, Sirloin, and Tenderloin Fillets!
The link between mortgages and financial freedom, grilling with Chef Ralph Pagano, and more!